A Promising New Biomarker Test Could Help Identify Alzheimer’s Risk Up To 10 Years Earlier
The biomarker test is a spinal tap test (also called a lumbar puncture) that uses a needle to remove cerebrospinal fluid (i.e ...
Ailing Northeast Philadelphia woman died after months of pleas for help, a victim of a safety net in tatters
Aging officials in Philadelphia took months to get Luen Ng help before she was killed. She’s one of 1,511 older adults who ...
Glamour on MSN4d
Wendy Williams’s Conservatorship: What We Know About the Star’s Health and Legal Struggles
A year after her team said she was diagnosed with aphasia and frontotemporal dementia, Williams claims she is “not ...
Ailing Pa. woman died after months of pleas for help, a victim of a safety net in tatters
The details involving the harrowing final days in cases like Ng’s illustrate the fragility and inadequacy of Pennsylvania’s ...
FDA fast tracks NKGen's Alzheimer's therapy troculeucel
SANTA ANA, Calif. - NKGen Biotech, Inc. (NASDAQ: NKGN), a clinical-stage biotechnology company with a current market capitalization of $17 million, has received Fast Track designation from the U.S.
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2025 Earnings Call Transcript
Good morning, everyone, and welcome to the Anavex Life Sciences Fiscal 2025 First Quarter Conference Call. My name is Clint ...
pharmaphorum2d
Bayer cues up filings for rival to Astellas’ menopause drug
The company hasn’t given a timeline for those regulatory filings but will no doubt want to move quickly as it chases after Astellas, which claimed approval for NK 3 antagonist Veozah ...
News Medical on MSN1d
Lecanemab and donanemab slow Alzheimer’s decline, but is the benefit worth the cost?
Study finds that disease-modifying therapies for Alzheimer’s, lecanemab and donanemab, can extend independence in daily ...